The Role and Importance of Intellectual Property Generation and Protection in Drug Development

Emerging Cancer Therapy: Microbial Approaches and Biotechnological Tools

Volumn , Issue , 2010, Pages 403-419

  Fialho, Arsénio M ^a   Chakrabarty, Ananda M ^b  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Expressed sequence tag (EST) patenting as lacking utility, and not meeting statutory requirements of patentability; Patents on bacteria bacterial products as anticancer agents; Role and importance of intellectual property generation and drug development protection

Indexed keywords

EID: 84886815296     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470626528.ch18     Document Type: Chapter

References (8)

1. Resnick D.B. and De Ville K.A. 2002 . Bioterrorism and patent rights: compulsory licensure and the case of Cipro . Am. J. Bioeth. 2: 29-39 .
2. Chakrabarty A.M. 2002 . Compulsory licensure: the case of Cipro and beyond . Am. J. Bioeth. 2: 40 .
3. Eisenberg R.S. 2002. How can you patent genes? Am. J. Bioeth. 2: 3-11 .
4. Doll J.J. 1998 . The patenting of DNA . Science. 280: 689-690 .
5. Chakrabarty A.M. 2003 . Patenting life forms: yesterday, today and tomorrow . In: Kieff F.S. , ed. Perspectives on Properties of the Human Genome Project . San Diego, CA: Elsevier Academic Press , pp. 3-11 .
6. Caulfield T. , Cook-Deegan R.M. , Kieff F.S. , and Walsh J.P. 2006 . Evidence and anecdotes: an analysis of human gene patenting controversies . Nat. Biotechnol. 24: 1091-1094 .
7. Hopkins M.M. , Mahdi S. , Patel P. , and Thomas S.M. 2007 . DNA patenting: the end of an era? Nat. Biotechnol. 25: 185-187 .
8. Holman C.M. 2008 . Trends in human gene patent litigation . Science 322: 198-199 .